Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

C4 Therapeutics (CCCC) Debt Ratio (2020 - 2023)

Historic Debt Ratio for C4 Therapeutics (CCCC) over the last 4 years, with Q2 2023 value amounting to 0.03.

  • C4 Therapeutics' Debt Ratio rose 2203.13% to 0.03 in Q2 2023 from the same period last year, while for Jun 2023 it was 0.01, marking a year-over-year increase of 1299.75%. This contributed to the annual value of 0.03 for FY2022, which is 2542.18% up from last year.
  • As of Q2 2023, C4 Therapeutics' Debt Ratio stood at 0.03, which was up 2203.13% from 0.03 recorded in Q1 2023.
  • C4 Therapeutics' 5-year Debt Ratio high stood at 0.04 for Q3 2020, and its period low was 0.02 during Q2 2021.
  • Over the past 4 years, C4 Therapeutics' median Debt Ratio value was 0.02 (recorded in 2020), while the average stood at 0.03.
  • Its Debt Ratio has fluctuated over the past 5 years, first crashed by 5164.1% in 2021, then surged by 2973.3% in 2023.
  • Over the past 4 years, C4 Therapeutics' Debt Ratio (Quarter) stood at 0.03 in 2020, then dropped by 15.42% to 0.02 in 2021, then rose by 25.42% to 0.03 in 2022, then increased by 3.41% to 0.03 in 2023.
  • Its Debt Ratio was 0.03 in Q2 2023, compared to 0.03 in Q1 2023 and 0.03 in Q4 2022.